ESMO: Merck & Co Vibostolimab Data Are Another Validation Of TIGIT

Shows Promise Alone And In Keytruda Combo

 
• By Kevin Grogan
  
Race_Cars_Children
Merck And Roche Jostling For Position In TIGIT Race • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Immuno-oncology

More from Anticancer